BI 705564 in Patients With Systemic Lupus Erythematosus (SLE)

Stopped Based on a strategic decision, the application for the trial has been withdrawn before initiation.

Conditions

• Lupus Erythematosus, Systemic

Interventions

• DRUG: BI 705564
• DRUG: Placebo

Sponsor

Boehringer Ingelheim